Richard I. Steinhart Joins Atossa Genetics' Board of Directors
March 03, 2014 12:30 ET
|
Atossa Genetics Inc.
SEATTLE, WA--(Marketwired - Mar 3, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS), announced today that Richard I. Steinhart has joined the Company's Board of Directors and has been appointed a Member...
Atossa Genetics Inc. Announces Pricing of a Public Offering of Common Stock and Warrants
January 24, 2014 08:30 ET
|
Atossa Genetics Inc.
SEATTLE, WA--(Marketwired - Jan 24, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has priced a public offering of approximately 5.8 million units at a price to the public of...
Atossa Genetics Inc. Announces Proposed Public Offering of Common Stock and Warrants
January 23, 2014 16:15 ET
|
Atossa Genetics Inc.
SEATTLE, WA--(Marketwired - Jan 23, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it intends to offer units consisting of shares of common stock and warrants in a public...
Atossa Genetics to Present at Two Upcoming Investor Conferences
January 09, 2014 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences:...
Atossa Genetics to Present at the 2013 Aegis Capital Healthcare Conference
September 24, 2013 10:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, Chief Financial Officer & General Counsel,...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference & Exhibition
September 19, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 19, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the Pri-Med East 2013 Conference...
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
September 18, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 18, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that it has entered into a nationwide distribution agreement with...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Breast Cancer Symposium 2013
September 06, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 7th annual Breast Cancer...
Atossa Genetics Reports Second Quarter 2013 Results and Operating Highlights
August 14, 2013 16:01 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its second quarter 2013 financial results and corporate...
New ASCO Clinical Practice Guideline for Breast Cancer Risk Reduction May Be Insufficient for Widespread Reduction, Atossa Genetics Says
August 05, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Aug 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, said that the new ASCO clinical practice guideline for the use of pharmacologic...